Iovance Biotherapeutics Inc (NASDAQ:IOVA)
| 25.48 Delayed Data As of Sep 17 |  +1.93 / +8.20%Today’s Change | 15.88 Today|||52-Week Range 54.21 | -45.09% Year-to-Date |
Institutional investors purchased a net $8.0 million shares of IOVA during the quarter ended June 2019 and now own 103.27% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
| Other institutional | 51.88% |
| Mutual fund holders | 51.39% |
| Individual stakeholders | 0.60% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 6/30/2021 | ARMISTICE CAPITAL LLC Bought 3.4 Million shares of Iovance Biotherapeutics I... |
| 6/30/2021 | NIKKO ASSET MANAGEMENT CO., LTD. Bought 2.4 Million shares of Iovance Biotherapeutics I... |
| 6/30/2021 | NIKKO ASSET MANAGEMENT AMERICAS,... Bought 2.4 Million shares of Iovance Biotherapeutics I... |
Top 10 Owners of Iovance Biotherapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 11.90% | 18,450,713 | 444,108,662 | -1,275,937 | -6.47% |
| The Vanguard Group, Inc. | 7.77% | 12,043,335 | 289,883,073 | +195,284 | +1.65% |
| Perceptive Advisors LLC | 7.07% | 10,959,772 | 263,801,712 | +2,307,987 | +26.68% |
| Avoro Capital Advisor LLC | 5.87% | 9,100,000 | 219,037,000 | +1,100,000 | +13.75% |
| Nikko Asset Management Co., Ltd. | 4.99% | 7,737,618 | 186,244,465 | +2,434,885 | +45.92% |
| Nikko Asset Management Americas, ... | 4.98% | 7,724,788 | 185,935,647 | +2,378,927 | +44.50% |
| Wellington Management Co. LLP | 4.68% | 7,251,243 | 174,537,419 | +3,586 | +0.05% |
| Franklin Advisers, Inc. | 4.63% | 7,183,701 | 172,911,683 | -1,787,270 | -19.92% |
| BlackRock Fund Advisors | 3.93% | 6,092,345 | 146,642,744 | -707,899 | -10.41% |
| Farallon Capital Management LLC | 3.39% | 5,250,000 | 126,367,500 | +500,000 | +10.53% |
Top 10 Mutual Funds Holding Iovance Biotherapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| ARK Innovation ETF | 4.20% | 6,515,347 | 156,824,402 | 0 | 0.00% |
| ARK Genomic Revolution ETF | 3.94% | 6,107,375 | 147,004,516 | +3,074 | +0.05% |
| Hartford Mid Cap Fund | 3.11% | 4,813,883 | 115,870,164 | +489,730 | +11.33% |
| Nikko AM Global Umbrella Fund - A... | 2.99% | 4,636,379 | 111,597,643 | +1,161,802 | +33.44% |
| Vanguard Total Stock Market Index... | 2.37% | 3,675,991 | 88,481,103 | -7,809 | -0.21% |
| Vanguard Small Cap Index Fund | 2.09% | 3,242,396 | 78,044,472 | +6,420 | +0.20% |
| FTIF SICAV - Biotechnology Discov... | 1.56% | 2,419,535 | 58,238,207 | 0 | 0.00% |
| SPDR S&P Biotech ETF | 1.35% | 2,087,035 | 50,234,932 | -31,042 | -1.47% |
| Nikko AM Global Umbrella Fund - A... | 1.34% | 2,077,717 | 50,010,648 | +2,077,717 | -- |
| Vanguard Extended Market Index Fu... | 1.34% | 2,069,721 | 49,818,184 | +2,341 | +0.11% |